Fischer Medical Ventures Limited

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹39.27
Market cap
2,570 Cr
Stock P/E
56.8
P/B
6.67
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales21 Cr10 Cr40 Cr12 Cr49 Cr23 Cr86 Cr101 Cr98 Cr
Operating expenses (approx.)18 Cr10 Cr39 Cr11 Cr47 Cr12 Cr68 Cr78 Cr95 Cr
EBITDA3 Cr-0.18 Cr0.49 Cr0.50 Cr2 Cr12 Cr19 Cr23 Cr2 Cr
OPM %12.1%-1.7%1.2%4.2%4.9%50.0%21.7%22.4%2.3%
Other income0.47 Cr0.74 Cr0.22 Cr0.38 Cr0.15 Cr7 Cr2 Cr1 Cr1 Cr
Interest0.05 Cr0.13 Cr0.05 Cr0.07 Cr0.23 Cr0.67 Cr0.92 Cr0.64 Cr4 Cr
Depreciation0.18 Cr0.28 Cr0.29 Cr0.56 Cr0.51 Cr0.77 Cr0.51 Cr0.77 Cr0.93 Cr
Profit before tax3 Cr0.16 Cr0.38 Cr0.25 Cr2 Cr10 Cr17 Cr21 Cr-2 Cr
Tax %6.1%118.3%-21.8%167.3%27.6%50.2%19.5%9.2%-215.5%
Net profit3 Cr-0.12 Cr0.29 Cr-0.29 Cr1 Cr5 Cr14 Cr19 Cr-7 Cr
EPS (₹)₹0.65₹0.16₹0.05₹-0.05₹0.09₹0.77₹2.15₹0.30₹-0.11

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales21 Cr111 Cr309 CrSign in for TTM
Operating expenses (approx.)19 Cr108 Cr253 CrSign in for TTM
EBITDA2 Cr3 Cr55 CrSign in for TTM
OPM %8.9%2.6%18.0%Sign in for TTM
Other income0.50 Cr1 Cr12 CrSign in for TTM
Interest0.07 Cr0.47 Cr6 CrSign in for TTM
Depreciation0.18 Cr2 Cr3 CrSign in for TTM
Profit before tax2 Cr2 Cr47 CrSign in for TTM
Tax %12.9%45.7%32.9%Sign in for TTM
Net profit2 Cr1 Cr31 CrSign in for TTM
EPS (₹)₹1.67₹0.22₹0.48Sign in for TTM
Dividend payout %0.0%0.0%0.9%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital54 Cr64 Cr65 Cr
Reserves27 Cr244 Cr320 Cr
Borrowings2 Cr60 Cr72 Cr
Other liabilities4 Cr59 Cr214 Cr
Total liabilities86 Cr457 Cr671 Cr
Fixed assets (net)9 Cr14 Cr12 Cr
CWIP—1 Cr3 Cr
Investments1 Cr11 Cr118 Cr
Other assets70 Cr365 Cr418 Cr
Total assets86 Cr457 Cr671 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity-7 Cr-86 Cr-101 Cr
Cash from investing-31 Cr-125 Cr-5 Cr
Cash from financing37 Cr315 Cr14 Cr
Net cash flow-2 Cr103 Cr-92 Cr
Free cash flow (OCF − Capex)-8 Cr-92 Cr-103 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %2.0%0.3%11.5%
ROE %2.3%0.4%8.1%
Debtor days398250—
Inventory days1043074
Days payable5068—
Cash conversion cycle45221274
Debt / equity0.020.180.19
Current ratio18.424.481.62
Net debt / EBITDA0.39-15.501.09

Compare with peers

Loading peers…